Ginte Kutkaite

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Cell Proliferation

Acute Lymphoblastic Leukemia

Top Venues

Nature communications

Communications biology

This page only lists publications with an associated author ORCID identifier.

Publications

Irineos Papakyriacou, Ginte Kutkaite, Marta Rúbies Bedós, Divya Nagarajan, Liam P Alford, Michael Patrick Menden, Yumeng Mao
Loss of NEDD8 in cancer cells causes vulnerability to immune checkpoint blockade in triple-negative breast cancer. Nature communications 15 (1) (2024)
Irineos Papakyriacou, Ginte Kutkaite, Marta Rúbies Bedós, Divya Nagarajan, Liam P Alford, Michael Patrick Menden, Yumeng Mao
Loss of NEDD8 in cancer cells causes vulnerability to immune checkpoint blockade in triple-negative breast cancer. Nature communications 15 (1) (2024)
Irineos Papakyriacou, Ginte Kutkaite, Marta Rúbies Bedós, Divya Nagarajan, Liam P Alford, Michael Patrick Menden, Yumeng Mao
Loss of NEDD8 in cancer cells causes vulnerability to immune checkpoint blockade in triple-negative breast cancer. Nature communications 15 (1) (2024)
Alexander Joschua Ohnmacht, Anantharamanan Rajamani, Göksu Avar, Ginte Kutkaite, Emanuel Gonçalves, Dieter Saur, Michael Patrick Menden
The pharmacoepigenomic landscape of cancer cell lines reveals the epigenetic component of drug sensitivity. Communications biology 6 (1) (2023)
Maryam Ghalandary, Yuqiao Gao, Diana Amend, Ginte Kutkaite, Binje Vick, Karsten Spiekermann, Maja Rothenberg-Thurley, Klaus H Metzeler, Anetta Marcinek, Marion Subklewe, Michael Patrick Menden, Vindi Jurinovic, Ehsan Bahrami, Irmela Jeremias
WT1 and DNMT3A play essential roles in the growth of certain patient AML cells in mice. Blood (2022)
Dennis Wang, James Hensman, Ginte Kutkaite, Tzen S Toh, Ana Galhoz, null null, Jonathan R Dry, Julio Saez-Rodriguez, Mathew J Garnett, Michael Patrick Menden, Frank Dondelinger
A statistical framework for assessing pharmacological responses and biomarkers using uncertainty estimates. eLife 9 (2020)